This study is currently recruiting

Description: This is a clinical research study of a medication that may treat both anxiety and epilepsy. The study will be for 16 weeks with 11 study visits.

Eligibility & Criteria

IRB #: 00282248

Principal Investigator: Jay Salpekar, MD

Eligible Age Range: Ages 6 to 17

Diagnosis: Children and adolescents with seizures who often are nervous or afraid.

Contact Information: Call the Clinical Trials Unit at Kennedy Krieger Institute at 443-923-3850 or email

Click here to view study flyer.